Frank Frissora Selected Research

tyrosinol

6/2011

OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frank Frissora Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 01/2008
2	Leukemia 01/2021 - 01/2008
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2008
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021
1	Disease Progression 01/2019
1	Burkitt Lymphoma (Burkitt's Lymphoma) 06/2011
1	Lymphoma (Lymphomas) 01/2008
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2008

Drug/Important Bio-Agent (IBA)

1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2021
1	venetoclaxIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 06/2011
1	tyrosinolIBA 06/2011
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2008

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2011
1	Drug Therapy (Chemotherapy) 01/2021
1	Euthanasia (Mercy Killing) 01/2019